Bausch Health
BHC
#3686
Rank
NZ$4.94 B
Marketcap
$13.36
Share price
0.39%
Change (1 day)
12.53%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - P/B ratio

P/B ratio as of December 2024 : -11.7

According to Bausch Health 's latest financial reports the company has a price-to-book ratio of 0.298869.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Bausch Health - P/B ratio (from 2001 to 2023)

P/B ratio by year

Year P/B ratio Change
2024-12-31-11.9-66.89%
2023-12-31-35.8-508.55%
2022-12-318.77-103.03%
2021-12-31-290-2482.1%
2020-12-3112.231.65%
2019-12-319.24300.81%
2018-12-312.3088.45%
2017-12-311.22-20.66%
2016-12-311.54-73.25%
2015-12-315.76-35.05%
2014-12-318.8719.09%
2013-12-317.4552.76%
2012-12-314.8833.29%
2011-12-313.66110.06%
2010-12-311.746.26%
2009-12-311.6431.7%
2008-12-311.24-25.49%
2007-12-311.67-35.94%
2006-12-312.61-15.99%
2005-12-313.1024.14%
2004-12-312.50-7.2%
2003-12-312.69-45.45%
2002-12-314.94

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
3.48-129.70%๐Ÿ‡บ๐Ÿ‡ธ USA
0.7718-106.60%๐Ÿ‡บ๐Ÿ‡ธ USA